L-GLUTAMINE
Generic: L-GLUTAMINE
ANI PharmaceuticalsManufacturer
ORALRoute
GLUTAMINEActive Substance
2024-07-08Original Approval
L-GLUTAMINE is FDA application ANDA215647, sponsored by NOVITIUM PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
NAUSEA
40 reports
2
SICKLE CELL ANAEMIA WITH CRISIS
38 reports
3
FATIGUE
29 reports
4
PAIN
24 reports
5
DRUG INEFFECTIVE
20 reports
6
HEADACHE
19 reports
7
DIZZINESS
17 reports
8
ARTHRALGIA
16 reports
9
CONSTIPATION
16 reports
10
PRODUCT DOSE OMISSION ISSUE
16 reports